logo

For the Inventor, By the Inventor

Washington, DC, United States of America

Vanda Pharmaceuticals Inc.


USPTO Granted Patents = 116



Trademarks = 19

Forward Citations = 358

Loading Chart...
Loading Chart...

46 inventors (with patents filed for the assignee):

goldMedal Mihael Hristos Polymeropoulos (78 out of 84 patents)

silverMedal Louis William Licamele (45 out of 45 patents)

bronzeMedal Marlene Michelle Dressman (30 out of 30 patents)

4.  Christian Lavedan (28 out of 28 patents)

5.  Deepak Phadke (18 out of 19 patents)

6.  John Joseph Feeney (15 out of 16 patents)

7.  Simona Volpi (15 out of 15 patents)

8.  Curt Douglas Wolfgang (14 out of 18 patents)

9.  Paolo Baroldi (9 out of 9 patents)

10.  Natalie M Platt (8 out of 8 patents)

11.  Ravi K Pandrapragada (8 out of 8 patents)

12.  Sandra Smieszek (7 out of 7 patents)

13.  Gunther Birznieks (5 out of 5 patents)

14.  Kendra Tomino Mack (3 out of 3 patents)

15.  Callie Michelle Heaton (3 out of 3 patents)


Core Competencies:
Cancer Treatment
Schizophrenia
Circadian Rhythm Disorders
Tasimelteon
Tradipitant
Multiple Sclerosis
Cognitive Enhancement
Pharmaceutical Combinations
Dosing Regimen
Genetic Markers
Fatigue-Related Symptoms
Atopic Dermatitis

116 patents:

1. 12728116 - Methods of treating multiple sclerosis (2026-09-08),
2. 12673055 - Treatment of atopic dermatitis with tradipitant (2026-07-07),
3. 12673033 - Multiple myeloma treatment (2026-07-07),
4. 12622915 - Methods of treating PDE IV-mediated diseases or conditions (2026-05-12),
5. 12590162 - Cancer treatment (2026-03-31),
6. 12582640 - Treatment of lower respiratory tract infection with tradipitant (2026-03-24),
7. 12544367 - Method of treatment of schizophrenia (2026-02-10),
8. 12527772 - Pharmaceutical combination comprising ponesimod (2026-01-20),
9. 12502379 - Ponesimod for avoiding worsening of fatigue-related symptoms in multiple sclerosis patients (2025-12-23),
10. 12478619 - Method of treatment with milsaperidone (2025-11-25),
11. 12447141 - Liquid tasimelteon formulations and methods of use thereof (2025-10-21),
12. 12440470 - Liquid tasimelteon formulations and methods of use thereof (2025-10-14),
13. 12427132 - Method of improving sleep (2025-09-30),
14. 12419869 - Methods of treating multiple sclerosis (2025-09-23),
15. 12409167 - Pharmaceutical combination comprising a selective S1Preceptor agonist (2025-09-09),
Vanda Pharmaceuticals Inc. is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs. With a diverse portfolio of products and a commitment to advancing scientific research, Vanda Pharmaceuticals aims to improve the lives of patients suffering from central nervous system disorders.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Vanda Pharmaceuticals Inc.
116 Patents

#19 in Washington, DC

#19 in District of Columbia

#3,314 in US

#6,836 in the World

Washington, DC (US)
Washington, DC, United States of America

Vanda Pharmaceuticals Inc.

Forward Citations = 358

46 inventors:

goldMedal Mihael Hristos Polymeropoulos (78 out of 84 patents)

silverMedal Louis William Licamele (45 out of 45 patents)

bronzeMedal Marlene Michelle Dressman (30 out of 30 patents)

4.  Christian Lavedan (28 out of 28 patents)

5.  Deepak Phadke (18 out of 19 patents)

Please report any incorrect information to [email protected]
Loading…